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INTRODUCTION
Paraquat (1,1′ -dimethyl-4,4′ -bipyridium dichloride, PQ)
is one of the most widely used herbicides in the world. In
humans, intentional or accidental, ingestion of PQ is frequent-
ly fatal, resulting from significant lung injury (1). Over the
past 30 yr, several methods for modifying the toxicity of PQ
have been examined including prevention of absorption from
the gastrointestinal tract (2, 3), removal from the bloodstream
(4, 5), prevention of accumulation in the lungs (6, 7), scav-
enging oxygen free radicals (8, 9), and prevention of lung
fibrosis (10, 11). Unfortunately, most of these methods have
not been effective; the outcome is determined by the degree
of exposure to PQ.
The mortality rate after PQ poisoning is strongly affected
by the plasma PQ levels as well as the amount of the PQ
intake (12-15). Consistent with this, it is clear that hemodial-
ysis (HD) or hemoperfusion (HP) is a critical factor during
the initial stages of intoxication. In agreement with previ-
ous reports, we recently reported that PQ clearance is more
effective with HP than with HD (16). However, there are
no reports on the positive effects of HP after PQ poisoning
(17-20). Therefore, it is unclear to nephrologists and/or the
toxicologist how to eliminate PQ from the system of patients
with acute PQ intoxication. We have reviewed previous reports
to determine what the specific concerns have been with HP
and PQ elimination. We found that the efficacy of HP elim-
ination was not evaluated properly in most prior studies (17-
21).
The kidney has been shown to eliminate PQ very effective-
ly, even better than creatinine elimination (22, 23). Howev-
er, some degree of renal failure is frequently observed with
acute PQ intoxication (21-24). This study was designed to
determine the efficacy of PQ elimination with HP, taking
into account renal elimination, in acute PQ intoxication.
MATERIALS AND METHODS
This study was approved by ethics committee of Soonchun-
hyang University Cheonan hospital and received a written
consent from the subjects and/or their family. Ten patients
(6 males and 4 females, between 25 and 70) with acute PQ
intoxication were enrolled in this study (Table 1). The inges-
tion amount of PQ was 153.0±89.3 mL of 23.1% PQ solu-
tion and the time lag from PQ ingestion to the emergency
room evaluation was 4.5±2.8 hr. The dithionite urine test
was strongly positive in all of the subjects. Two patients sur-
vived and eight patients within the fifth hospital day. Table
2 summarizes the laboratory findings measured in the emer-
gency room.
The dithionite urine test was carried out in the emergen-
cy room, as soon as the patient arrived and was considered to
have acute PQ intoxication. All of the patients underwent HP
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Comparison between Kidney and Hemoperfusion for Paraquat
Elimination
The mortality rate of acute paraquat (PQ) poisoning depends on the PQ concentra-
tion in the blood. It has been shown that the kidneys eliminate PQ effectively. How-
ever, early renal function deterioration is frequently observed in acute PQ intoxica-
tion. This study is designed to compare the efficacy of PQ elimination with hemop-
erfusion (HP) and kidneys, taking into account the functional deterioration of the
kidneys. The amount of renal and HP excretion of PQ were measured during the
procedure of HP in patients with acute PQ intoxication. The PQ clearance and the
actual amount of PQ elimination by the HP cartridge during the HP procedure were
111± ±11 mL/min (range; 13.2-162.2 mL/min) and 251.4± ±506.3 mg (range; 4.6-
1,655.7) each. While, the renal clearance and actual amount of renal elimination of
PQ was 79.8± ±56.0 mL/min (range; 9.7-177.0) and 75.4± ±73.6 mg (range; 4.9-
245.8). As the creatinine clearance decreased, the PQ elimination by HP was as
effective as or more effective than the renal elimination. In conclusion, early HP
must be provided for life saving treatment in patients with acute PQ intoxication.
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as long as the vital signs were stable. HP was carried out thro-
ugh a jugular venous catheter for three hr at a blood flow rate
of 200 mL/min. The HP membrane used was an adsorba 300
C, Gambro (Gambro Dialysatoren GmbH Co., KG Hechin-
gen, Germary) that had polypropylene housing material, acti-
vated charcoal adsorbent, a 300 m2 surface area, and cellulose
coating material for the adsorbent.
Blood samples for PQ and creatinine were obtained from
the arterial and venous lines of the tubing system at time 0,
1 hr, 2 hr, and 3 hr of HP. Urine samples were collected every
hour during the HP procedure through a urinary catheter. Plas-
ma and urine samples for the PQ assay were stored at -70℃
until high performance liquid chromatography was performed.
Renal excretion of PQ
The amount of renal excretion of PQ (KEPQt1-2) at each
time point was calculated according to 
KEPQt1-2 (mg)=uCo of PQt1-2 ×UVt1-2------------------ (1)
Where (uCo of PQt1-2)=urinary PQ level and (UVt1-2)
=timed volume of urine
The renal clearance of PQ (KCPQt1-2 [mL/min]) was calcu-
lated by using PQ level in plasma and urine 
KCPQt1-2 (mL/min)=KEPQt1-2/AUC t1-t2 ----------------- (2)
Where AUC is the area under the plasma PQ level-timed
curve
AUC=([pCo of PQ {t1}+pCo of PQ {t2}]/2)/t1-2 (hr) ---- (3) 
HP elimination rate of PQ
The PQ extraction ratio (ER) of HP at each time point
was calculated according to
ER=(A-V)/A----------------------------------------------- (4)
Where A=inlet plasma PQ level and V=outlet plasma PQ
level.
The PQ clearance of HP (HPCPQt1-2) at each time point
was calculated according to
HPCPQt1-2=ER×BFR×(1-Hct)------------------------- (5)
Where BFR=blood flow rate and Hct=hematocrit.
The amount of PQ adsorbed by the cartridges (HPEHPt1-2)
at each time point was calculated from the equation (6)
HPEHPt1-2=HPCPQt1-2× AUC---------------------------- (6)
Where AUC is the area under the plasma PQ level-timed
curve
*Time lag means the period between PQ ingestion and arrival to the emergency room of Soonchunhyang Cheonan Hospital.
PQ, paraquat.
Case no Sex Age (yr)
Amounts of Time lag Plasma PQ Clinical
ingestion (mL) (hr)* (μ g/mL) outcome
1 M 68 200 4.0 48.7 Death
2 M 25 200 7.0 8.0 Death
3 F 33 100 5.5 1.2 Survivor
4 F 39 50 2.0 13.7 Death
5 M 50 300 11.0 12.7 Death
6 F 33 30 4.0 1.4 Survivor
7 F 76 250 4.5 21.8 Death
8 M 60 200 2.0 167.0 Death
9 M 47 100 3.0 33.0 Death
10 M 61 100 2.0 30.7 Death
Table 1. Age, sex, and PQ levels of the subjects at emergency room
Note that serum creatinine, amylase, lipase, and hypoxia have known as predictive factors for clinical outcome in acute paraquat intoxication. 
WBC, white blood cell; BUN, blood urea nitrogen.
Case no WBC (/μ L)
Serum BUN Serum creatinine Amylase Lipase PaCO2 PaO2
(mg/dL) (mg/dL) (IU/L) (IU/L) (mmHg) (mmHg)
1 29,980 18.4 1.6 98 56 18.1 114.7
2 18,470 14.1 1.6 192 28 32.6 74.8
3 7,530 6.1 0.3 91 45 31.0 109.4
4 13,380 10.7 0.8 402 52 22.9 135.5
5 19,580 15.0 0.7 218 47 34.5 98.8
6 10,840 10.8 0.4 86 25 34.9 97.2
7 25,990 10.8 0.8 143 21 28.7 74.2
8 15,710 17.1 3.0 171 67 17.4 92.1
9 35,740 8.6 1.2 51 24 19.9 132.3
10 8,980 15.6 0.9 219 76 20.0 62.3
Table 2. Laboratory findings of the cases at the emergency roomS158 M.-S. Kang, H.-W. Gil, J.-O. Yang, et al.
Statistical analysis
The results are expressed as means and standard deviation.
The significance of the measured differences, between patients
with renal failure and those with normal renal function were
analyzed by the non-parametric paired t-test. A probability
value of p<0.05 was considered significant.
RESULTS
HP elimination of PQ
The PQ reduction rate with the HP cartridges was 0.94±
0.04 throughout the HP period. The PQ clearance was 111
±11 mL/min (range; 13.2-162.2 mL/min) and the actual
amount of PQ elimination by the HP cartridge was 251.4
±506.3 mg (range; 4.6-1,655.7 mg).
Renal elimination of PQ during the HP
The urine volume during the HP three hours was 3,300±
1,600 mL. The overall creatinine clearance was 79.8±56.0
mL/min (range; 9.7-177.0 mL/min) and the PQ clearance was
98.6±53.8 mL/min (range; 13.2-162.2 mL/min). The actu-
al renal elimination of PQ during the HP procedure was 75.4
±73.6 mg (range; 4.9-245.8 mg).
Comparison between HP and kidney for PQ elimination
The effect of the plasma PQ level on both the kidneys and
HP showed that the renal PQ elimination was higher than that
of the HP, in cases with plasma PQ levels lower than 1.0 μ g/
mL. However, the elimination of PQ was higher with the HP
when the PQ level in the plasma was higher than 1.0 μ g/mL
(Fig. 1).
The effect of the creatinine clearance on the PQ elimina-
tion for both the renal and HP clearance showed that as long
as the renal function stayed within the normal range, the renal
PQ elimination rate was higher or just as good as the HP
elimination. However, as the creatinine clearance decreased,
the PQ elimination by HP was as effective as or more effec-
tive than the renal elimination (Fig. 2).
DISCUSSION
The plasma PQ level changes by unique kinetics, reaching
a peak level very early about 60-90 min after ingestion upon
disruption of the gastric mucosal barrier (22, 25). Once the
peak is reached, the level slopes down rapidly even without
extracorporeal elimination (22). Therefore, the toxicokinetics
at a given time should be interpreted along with the plasma
levels of PQ. A three-compartment model has been proposed
for the most accurate description of the PQ distribution: 1)
Plasma compartment, 2) Compartment with rapid uptake
and removal such as the kidney, and a 3) Slow uptake com-
partment such as the lungs, reaching a maximum concentra-
tion about 4-5 hr after ingestion regardless of the plasma PQ
level (22). This model explains the plasma PQ level changes
by not only renal excretion factors but also the involvement
of other tissue adsorption of PQ.
The efficacy of HP in eliminating PQ is a function of the
Fig. 1. Comparison between Kidney and HP elimination according
to PQ concentration. Note that the intersection of the two lines from
the renal and HP elimination equation was at 5.3 μ g/mL.
PQ, paraquat; HP, hemoperfusion.
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reduction rate of the HP cartridge, the blood flow and the
plasma levels. In our study, the reduction rate was 0.94±0.04,
which showed high efficacy throughout the three hours of
HP in all subjects. With an almost constant reduction rate
and a fixed value for the blood flow, the main variable factor
of the HP for the elimination of PQ appears to depend on the
plasma levels of PQ. A linear correlation between the elimi-
nated amount of the PQ and the plasma PQ levels suggests
that an earlier initiation of HP, as early as the PQ peak, would
be the most effective method for the elimination of PQ.
The frequent deterioration of kidney function after PQ
intoxication makes its role in eliminating PQ complicated.
In agreement with previous reports (23, 24), the kidney elim-
inates more PQ than the HP, and can be very effective when
the creatinine clearance remains in the normal range (Fig. 1,
2). However, once the renal function begins to deteriorate so
does the ability to eliminate PQ (Fig. 1, 2).
Therefore, the efficacy of the kidneys and HP in the elim-
ination of PQ varies depending on a number of factors. The
kidney is very effective in eliminating PQ but vulnerable to
PQ injury. PQ is metabolized very poorly, and is excreted intact
in the urine (26). Renal injury is caused by reactive oxygen
species (ROS); their presence progresses very rapidly, causing
life threatening clinical features with acute PQ intoxication
(27, 28). Deterioration of renal function is frequently observed
early in patients with acute PQ intoxication when the PQ level
is more than the lethal level (21-24). Therefore, renal protec-
tion is critical during the early treatment of PQ intoxication.
The elimination of PQ during HP is limited by the blood
flow dynamics which is driven through a jugular venous ca-
theter at a rate of 200-300 mL/min in adults. Keeping in mind
both the large PQ distribution volume of 1.0-1.5 L/kg body
weight (22, 25) and the very rapid progression of ROS injury
with PQ intoxication, the PQ elimination process is pressed
for time and blood flow.
In conclusion, our results suggest that early HP must be
provided for life saving treatment in patients with acute PQ
intoxication, especially in early deterioration of renal function
or high plasma levels of PQ.
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